stockrowKrystal Biotech, Inc. (KRYS) vs Twist Bioscience Corporation (TWST)
- Krystal Biotech, Inc. KRYS 300.31 +0.02%
- Twist Bioscience Corporation TWST 119.38 −1.02%
Krystal Biotech, Inc. and Twist Bioscience Corporation are both Biotechnology companies. Krystal Biotech, Inc. is the larger, with a market value of $8.9B against $7.9B — 1.1× the size. Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 39.2×. Krystal Biotech, Inc. grew revenue faster over the last twelve months: 26.0% against 19.2%. Krystal Biotech, Inc. has the higher net margin (47.9% vs −31.7%) and the higher return on invested capital (27.2% vs −30.8%). Across the 17 metrics below, Krystal Biotech, Inc. leads on 16 and Twist Bioscience Corporation on 1.
Valuation
Profitability
| Metric | KRYS | TWST | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.27% | 51.97% | 65.16% |
| Operating margin | 48.41% | (33.58%) | 0.00% |
| Net margin | 47.91% | (31.66%) | 0.00% |
| Free cash flow margin | 65.97% | (22.15%) | 0.00% |
| Return on equity | 17.50% | (29.59%) | (50.12%) |
| Return on assets | 15.93% | (20.78%) | (45.60%) |
| Return on invested capital | 27.15% | (30.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack